News

Pharmabiz47m
Medicenna strengthens IP portfolio with five patents granted for its IL-2 and IL-4 Superkines
US Patent No. 12,202,873 – Superagonists, Partial Agonists and Antagonists of IL-2. Also granted in Switzerland, China, Germany, France, United Kingdom, India, and Japan and allowed in Canada with ...
Pharmabiz2h
UKHSA study shows RSV vaccine highly effective in preventing hospitalisation
UKHSA study shows RSV vaccine highly effective in preventing hospitalisation: United Kingdom Saturday, August 2, 2025, 10:00 Hrs [IST] A new UK Health Security Agency study - Effe ...
Pharmabiz1h
US FDA requires major changes to opioid pain medication labelling to emphasize risks
US FDA requires major changes to opioid pain medication labelling to emphasize risks: Maryland Saturday, August 2, 2025, 11:00 Hrs [IST] The US Food and Drug Administration (FDA) ...
Pharmabiz20h
Novo Nordisk appoints Mike Doustdar as new president and CEO
Novo Nordisk, a Danish multinational pharmaceutical company headquartered in Bagsværd with production facilities in nine ...
Pharmabiz4h
No impact going forward on the Indian pharma industry due to US tariff policy: IDMA
No impact going forward on the Indian pharma industry due to US tariff policy: IDMA: Shardul Nautiyal, Mumbai Saturday, August 2, 2025, 08:00 Hrs [IST] US President Donald Trumps ...
Pharmabiz4h
AI & biosensing technologies shaping health-tech start-ups to drive innovation in chronic disease prediction
AI & biosensing technologies shaping health-tech start-ups to drive innovation in chronic disease prediction: Nandita Vijayasimha, Bengaluru Saturday, August 2, 2025, 08:00 Hrs [I ...
Pharmabiz4h
Health ministry amends Cosmetics Rules, 2020 to add specifics for cancellation & suspension of licence
Health ministry amends Cosmetics Rules, 2020 to add specifics for cancellation & suspension of licence: Gireesh Babu, New Delhi Saturday, August 2, 2025, 08:00 Hrs [IST] The Union ...
Pharmabiz4h
Karnataka strengthens cleft lip & cleft palate care by training maxillofacial surgeons
Karnataka strengthens cleft lip & cleft palate care by training maxillofacial surgeons: Nandita Vijayasimha, Bengaluru Saturday, August 2, 2025, 08:00 Hrs [IST] Karnataka governme ...
Pharmabiz3h
Mallinckrodt & Endo complete merger to create global, scaled, diversified therapeutics leader
Mallinckrodt & Endo complete merger to create global, scaled, diversified therapeutics leader: Dublin Saturday, August 2, 2025, 09:00 Hrs [IST] Mallinckrodt plc, a leading provide ...
Pharmabiz4h
R Lalvena IAS appointed new director of TN DC department
The Department of Drug Control Administration (DCA) in Tamil Nadu has once again come under the direct leadership of an IAS officer, R Lalvena, following the recent arrest of its former director, P U ...
Pharmabiz18h
Harbour BioMed to present phase II data of HBM4003 & tislelizumab combination in MSS metastatic colorectal cancer at ESMO 2025
Harbour BioMed to present phase II data of HBM4003 & tislelizumab combination in MSS metastatic colorectal cancer at ESMO 2025: Cambridge, Massachusetts Friday, August 1, 2025, 18 ...
Pharmabiz21h
Madrigal Pharma inks exclusive global license agreement with CSPC Pharma for SYH2086, a preclinical oral small molecule GLP-1 receptor agonist
Conshohocken, Pa. Friday, August 1, 2025, 15:00 Hrs [IST] ...